We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MorphoSys Signs Agreement for Use of Antibody Technologies with Merck & Co.

News   Dec 14, 2005

 
MorphoSys Signs Agreement for Use of Antibody Technologies with Merck & Co.
 
 
Advertisement
 

RELATED ARTICLES

MS Drug Blocks HIV Infection and Transmission in Human Immune Cells

News

Fingolimod, an FDA-approved immunosuppressive drug used to treat multiple sclerosis, may be used to block HIV infection and reduce the latent reservoir.

READ MORE

The Microbiome’s Role in Attacking Cancerous Tumors

News

Researchers have discovered which gut bacteria help our immune system battle cancerous tumors and how they do it.

READ MORE

Infrastructure Needed For Biobanking the World's Microbiomes

News

Scientists have outlined a series of challenges and opportunities presented in a necessary review of how microbiomes can be "banked" and preserved for generations to come.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE